尽管其余的化疗后结局，在组间的差异无统计学意义（P＞0.05）；但大都

Although the remaining outcomes after chemotherapy were not statistically different between the groups (P>0.05); most of them showed a trend that the incidence in the debilitating group was higher than that in the non-debilitating group. If liver function is impaired, 7.5% of the debilitated group, while 5.9% of the non-debilitated group. See Table 3.

Although the differences between groups were not statistically significant in the rest of the post-chemotherapy outcomes (P>0.05); If liver function is impaired, the weakened group is 7.5%, while the non-debilitating group is 5.9%. See table 3.

Although there was no significant difference in the rest of the chemotherapy outcomes between the groups (P > 0.05), most of them showed a trend that the incidence in the weak group was higher than that in the non weak group. If the liver function was damaged, it was 7.5% in the weak group and 5.9% in the non weak group. See Table 3.<br>